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Although variants in the IGF2BP2/IMP2 gene confer
risk for type 2 diabetes, IMP2, an RNA binding pro-
tein, is not known to regulate metabolism. Imp2/
mice gain less lean mass after weaning and have
increased lifespan. Imp2/mice are highly resistant
to diet-induced obesity and fatty liver and display
superior glucose tolerance and insulin sensitivity,
increased energy expenditure, and better defense
of core temperature on cold exposure. Imp2/
brown fat and Imp2/ brown adipocytes differenti-
ated in vitro contain more UCP1 polypeptide than
Imp2+/+ despite similar levels of Ucp1 mRNA; the
Imp2/adipocytes also exhibit greater uncoupled
oxygen consumption. IMP2 binds themRNAs encod-
ing Ucp1 and other mitochondrial components, and
most exhibit increased translational efficiency in the
absence of IMP2. In vitro IMP2 inhibits translation
of mRNAs bearing the Ucp1 untranslated segments.
Thus IMP2 limits longevity and regulates nutrient and
energy metabolism in the mouse by controlling the
translation of its client mRNAs.
INTRODUCTION
Susceptibility to type 2 diabetes mellitus (T2DM) is strongly
influenced by both environmental (Knowler et al., 2002) andCgenetic factors (DIAGRAM Consortium, 2014). Genome-wide
association studies (GWAS) have mapped more than 70
genomic locations at which common SNPs are associated
with risk of T2D. Most variants map to noncoding regions,
making it difficult to implicate a specific gene(s) and mecha-
nisms at each locus. One of the first SNPs found by GWAS
for T2DM is located in intron 2 of the gene encoding the
RNA binding protein, IGF2 mRNA binding protein 2, abbrevi-
ated IGF2BP2 or IMP2 (Saxena et al., 2007; Zeggini et al.,
2007; Scott et al., 2007).
IMP1-3, named for their ability to bind to the leader 3 50 UTR of
human IGF2mRNA (Nielsen et al., 1999), participate in posttran-
scriptional RNA processing, i.e., RNA splicing, stabilization,
transport, and translation (Yisraeli, 2005) Considered ‘‘oncofe-
tal’’ proteins, expression of Imp1-3 in the mouse embryo peaks
coordinately at E12.5 (Nielsen et al., 1999), coinciding with the
expression of IGF2 polypeptide. Whereas the expression of
Imp1 and Imp3 is largely extinguished before birth (Nielsen
et al., 1999), Imp2 expression is widespread in the adult mouse
(Dai et al., 2011). Imp2 is phosphorylated by mTOR complex 1
in a rapamycin-sensitive manner (Dai et al., 2011), and trans-
genic overexpression of IMP2 in mouse liver results in steatosis
(Tybl et al., 2011). Nevertheless, little is known of IMP2’s physi-
ologic functions, and it is unclear whether and how the function
of IMP2 relates to the association with T2D of an intronic SNP in
the IMP2 gene.
To determine whether IMP2 contributes to metabolism, we
generated and characterized mice whose Imp2 gene is
inactivated. Imp2/ mice resist diet-induced obesity and
fatty liver due in part to increased energy expenditure (EE)
and have a prolonged lifespan. Imp2/ mice exhibit superiorell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc. 609
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Figure 1. IMP2 Affects Postnatal Growth,
Response to Fat Feeding, and Lifespan
(A) Fasting reduces IMP2 polypeptide in liver. Four
pairs of male mice 12 weeks of age maintained on
normal chow were deprived of food for 24 hr prior
to sacrifice.
(B) IMP2 abundance in liver and WAT is increased
by HFD and in obesity. (Upper) Six-week-old
C57Bl6 male mice were fed a HFD for 1 week and
sacrificed; (lower) 6-week-old male Lepob/ob mice
and wild-type littermates on NCD; extracts of liver
and gonadal fat were immunoblotted for IMP2 and
actin.
(C) Imp2 mRNA and protein expression in
mouse embryos. Extracts of wild-type and Imp2
knockout mouse embryos at E12.5 were analyzed
for Imp2 and actin mRNA (upper) and protein
(lower).
(D) Growth curves of wild-type and Imp2/ male
mice on normal chow and HFD. (Upper) Growth
curves on normal chow of wild-type and Imp2/
male mice; error bars, 1 SD. Body weight is not
different at 4 weeks (weaning) but is significantly
greater in the wild-type at 6 weeks and at all
times thereafter (*p < 0.05). (Right) Thirty-week-
old wild-type and Imp2/ female mice main-
tained on NCD. (Lower) Growth curves on a HFD
from 4 weeks of age; weight is not different at
4 weeks but is significantly greater in the wild-
type at 6 weeks of age (**p < 0.001) and there-
after. (Right) Thirty-week old wild-type and
Imp2/ female mice maintained on a HFD from
weaning.
(E) Effect of IMP2 deficiency on body composi-
tion. (Upper) Fat mass of wild-type (filled circles)
and Imp2/ (open circles) mice on NCD (solid
line) and HFD (dashed line), as estimated by MRI;
error bar, 1 SD. On the NCD, the fat mass in the
wild-type is not greater than the Imp2/ until
12 weeks of age (*p < 0.01); on the HFD, the fat
mass of the wild-type is larger at 8 weeks of age
(*p < 0.01). (Lower) Lean mass of wild-type (filled
circles) and Imp2/ (open circles) mice on NCD
(solid lines) and HFD, (dashed lines). Lean mass is
not different until 8 weeks of age on both diets
(*,*p < 0.01).
(F) Selected organ weights of wild-type (black
bars) and Imp2/ (white bars) mice maintained
on a HFD from weaning, expressed as % of
TBW (*p < 0.05). The upper graph summarizes
results from 12 pairs of females 30 weeks of age.
The lower graph shows results from eight pairs
of males, 32 weeks of age. Skeletal muscle is
sum of four hindlimb muscles (gastrocnemius, soleus, EDL, and tibialis anterior), and subcutaneous fat is the weight of the bilateral inguinal depots.
(G) Percent survival of wild-type (black) and Imp2/ mice (red) maintained on normal chow. The upper plot includes all animals; median survival,
Imp2/ > wild-type, p < 0.0001; the lower plots show females (30 Imp2+/+ and 34 Imp2/) on the left (p < 0.0005) and males (28 Imp+/+ and 31 Imp2/) on the
right (p < 0.001).defense of body temperature when placed at 4C, accompa-
nied by an increased abundance of uncoupling protein-1
(UCP1) in Imp2/ brown fat, whereas Ucp1 mRNA is not
altered. IMP2 binds Ucp1 mRNA and inhibits Ucp1 mRNA
translation. The loss of IMP2 and the consequent increase
in EE due to increased UCP1 contribute to a resistance to
obesity, a beneficial metabolic profile, and an increased
lifespan.610 Cell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc.RESULTS
IMP2 Abundance Is Regulated by Nutrition
IMP2 is widely expressed in the adult mouse (Dai et al., 2011).
While an overnight fast decreases IMP2 abundance in liver (Fig-
ure 1A), a high-fat diet (HFD) increases the abundance of IMP2 in
liver and white adipose tissue (WAT, Figure 1B, upper), and IMP2
abundance is higher in the fat pads of Lep/ mice (Figure 1B,
lower). Thus, increased intake and/or deposition of fat is accom-
panied by a leptin-independent increase in IMP2 abundance.
Imp2–/– Mice Are Lean and Resistant to Diet-Induced
Obesity
Imp2/mice (Figure 1C, see Figure S1 available online) are born
at the expected Mendelian ratio, appear normal at birth, survive
without difficulty, and are similar in weight to wild-type at wean-
ing (4 weeks of age). On normal chow diet (NCD), Imp2/ mice
gain less weight thereafter: at 30 weeks of age, the Imp2/mice
weigh 25% less than wild-type littermates (Figure 1D). More-
over, on a HFD the difference in weight gain between male
Imp2/ and wild-type littermates is exaggerated (Figure 1D,
lower left). Analysis of body composition bymagnetic resonance
imaging (ECHO-MRI) shows that whereas wild-type mice gain
17 g in fat between weaning and 28 weeks of age, the
Imp2/males gain6 g fat (Figure 1E, upper). Imp2/ females
on a HFD are also lean (Figure 1D, lower right). Thus the IMP2-
deficient mice are relatively resistant to diet-induced obesity.
Imp2–/– Mice Gain Less Lean Mass after Weaning and
Are Longer Lived Than Wild-Type
Imp2/ mice gain lean mass at a slower rate of than wild-type,
especially after 12 weeks of age (Figure 1E, lower). The lean
mass of Imp2/ males is 15% lower at 16 weeks and 25%
lower at 28 weeks, along with a 5% reduction in crown-to-
rump length (males at 14 weeks on normal chow: wild-type
9.8 ± 0.2 cm versus KO 9.3 ± 0.16 cm, p = 0.02). The smaller
leanmass of the Imp2/mice reflects a proportionate reduction
in size; direct measurement of organ weights from mice main-
tained on a HFD, when expressed as a fraction of body weight,
shows that only the mass of the white adipose depots and the
testes are selectively diminished; the weight of interscapular
brown fat is similar (Figure 1F). At all times, the fraction of body
weight contributed by fat mass is lower in the Imp2/ than in
wild-type mice.
Genetic modifications in mice that are associated with a
smaller, leaner phenotype (such as seen in the Imp2/) have
been associated with an extended lifespan. We maintained co-
horts of wild-type and Imp2/ mice on a normal chow without
intervention: Imp2/ mice exhibit a significantly longer median
lifespan than wild-type littermates, both in males and females
(Figure 1G). As compared to wild-type littermates, the median
survival of Imp2/ males was 120 days longer (846 versus
726 days) and of Imp2/ females was 183 days longer
(943 days versus 760 days). Maximum lifespan of Imp2/
mice is also increased. The age at 90% survival was 885 and
986 days for male wild-type and Imp2/ mice, respectively,
and 940 and 1,023 days for female wild-type and Imp2/
mice (including two Imp2/ females alive at 1,113 and
1,116 days). Combining the sexes, the last surviving 10% were
comprised of 2/58 wild-type and 10/65 Imp2/ mice, p = 0.03
(Wang et al., 2004). A caveat to the robust lifespan extension
of the Imp2/ mice as compared with wild-type is that the
median lifespan of our wild-type C57Bl/6J cohort, although
comparable to many earlier observations (mentioned in Turturro
et al., 2002), is shorter than that in several recent reports
(Turturro et al., 2002; http://research.jax.org/faculty/harrison/
ger1vi_LifeStudy1.html).CNecropsy was performed on an apparently healthy cohort of
six Imp2+/+ and six Imp2/ mice (five males and one female of
each genotype, all between 845 and 850 days age), taken from
a cohort of several litters born in the same week and sacrificed
at a time when 20% of the Imp2/ birth cohort had expired.
Malignant tumors were detected in 4/6 Imp2+/+ mice, whereas
nomalignancies were detected in the six Imp2/mice. Histopa-
tologic findings at necropsy for the individual mice are found in
the Supplemental Experimental Procedures.
Imp2–/– Mice Are Resistant to Fatty Liver
We examined the histology of tissues important to the regulation
of nutrient metabolism. Skeletal muscle of wild-type and
Imp2/ mice was indistinguishable by light or electron micro-
scopic examination (data not shown). Pancreatic morphology
was normal in the Imp2/ mice; immunohistochemical stains
for insulin and glucagon revealed a comparable abundance of
normal-appearing islets with a similar staining for glucagon in
Imp2/ and wild-type but a weaker signal for insulin in the
Imp2/ (Figure 2A), consistent with their lower serum insulin
level (see below). H&E sections of formalin-fixed white adipose
tissue show little or no difference in adipocyte size between
Imp2/ and wild-type mice, whether on normal chow or a
HFD (Figure 2B), a finding confirmed by sizing of osmium tetrox-
ide-fixed adipocytes (Figure S2A). The smaller white fat depots
in HFD-fed Imp2/ are thus due to fewer adult adipocytes,
accompanied by a reduced number of Lin-CD29+CD34+
Sca1+ preadipocytes in the stromal-vascular compartment;
the ability of the Imp2/ adipocyte precursors to proliferate
and differentiate in vitro, however, is not different than wild-
type (Figures S2B–S2G). Themorphology of interscapular brown
adipose tissue is similar in wild-type and Imp2/ mice fed
normal chow (data not shown); however, after 8 weeks on a
HFD the interscapular brown fat of wild-typemice has a distinctly
more pale appearance than the Imp2/ brown fat (Figure 2C,
left), due in part to greater fat deposition (Figure 2C, right).
The most striking difference in histologic appearance between
wild-type and Imp2/ mice is found in the liver of mice fed the
HFD. As expected, there was abundant deposition of fat in the
liver of wild-type mice fed the HFD. In contrast, little fat is seen
in the liver of Imp2/ mice (Figure 2D, left). This histological
appearance was confirmed by direct measurement of liver tri-
glyceride (Figure 2D, right). The hepatic transcriptional response
to the HFD was examined using high-throughput sequencing of
RNA extracted from the livers of wild-type and Imp2/ mice
placed on normal chow or a HFD immediately after weaning
and sacrificed 1 week later. Focusing on gene products relating
to fatty acid and triglyceride metabolism (Figure 2E), the modest
differences evident on normal chow are largely eliminated by
the HFD, suggesting that the lesser triglyceride deposition in
the Imp2/ liver is not attributable to an altered transcriptional
response.
Imp2 Null Mice Are Hypolipidemic, Glucose Tolerant,
and Insulin Sensitive
In Imp2/mice, serum-free fatty acids (FFAs), triglyceride (TG),
and total cholesterol (Table S1) were lower after a 6 hr (FFA/TG)
or overnight (cholesterol) fast, on both normal chow or a HFD,
and at all ages examined. On normal chow, blood glucose,ell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc. 611
Figure 2. Histology of Selected Organs, Liver Triglyceride Content, and Gene Expression on NCD and HFD
(A) Representative images of pancreatic islets from 19-week-old male mice maintained on HFD from weaning, stained for insulin (upper; scale bar, 250 mm) and
glucagon (lower; scale bar, 50 mm).
(B) Gonadal adipose tissue of 12-week-oldmale wild-type and Imp2/micemaintained on normal chow (upper) and HFD fromweaning (lower); scale bar, 50 mM.
See Figure S2.
(C) Interscapular brown adipose tissue from 12-week-oldmale wild-type and Imp2/micemaintained on a HFD fromweaning. (Upper) Gross appearance of the
depot from wild-type (left) and Imp2/ mice (right). The photomicrographs show H&E stains of tissue sections of BAT; scale bar, 50 mm.
(D) Liver fat content on a HFD. (Upper left) Liver from 19-week-old wild-type and Imp2/ male mice maintained on HFD, stained with H&E (scale bar, 250 mm).
(Left lower) Liver from 12-week-old wild-type and Imp2/ male mice maintained on HFD stained with oil red O (scale bar, 100 mM). (Right) Liver triglyceride
content of 16-week-old wild-type (black) and Imp2/ (white) male mice maintained on NCD (three pairs) or HFD (three pairs) from weaning; **p = < 0.01.
(E) Relative abundance of liver mRNAs encoding genes relevant to fat metabolism. Imp2+/+ and Imp2/ mice were weaned onto normal chow or a HFD and
sacrificed 1 week later.whether taken at 7 a.m. after feeding or after an overnight fast,
was significantly lower in the Imp2/ after 4 weeks of age (Fig-
ure 3A). On a HFD, the Imp2/ mice exhibited lower values of
fasting glucose (Figure 3A; Table S1) accompanied by lower612 Cell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc.levels of serum insulin (Table S1). Intraperitoneal glucose toler-
ance tests were performed on mice 12–14 weeks of age fed
a HFD from weaning; Imp2/ mice exhibited consistently lower
values of glucose and insulin (Figure 3B).
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Figure 3. Glucose and Insulin Responses in Wild-Type and Imp2–/– Mice
(A) Fasting blood glucose with age. Blood glucose (±1 SD) measured after ON fast in wild-type (filled circles) and Imp2/ (open circles) mice on NCD (solid line;
n = 8 each genotype) and HFD (dashed line; n = 8 each genotype). Values for fasting glucose are significantly different (at least p < 0.05) between wild-type and
Imp2/ at all times after 4 weeks (weaning) on both diets.
(B) Glucose tolerance tests. Glucose, 1 g/kg, was administered intraperitoneally after 14 hr fasting, in 12-week-old wild-type (filled circles; n = 8) and Imp2/
(open circles; n = 8) male mice maintained on HFD. The glucose (±1 SD) and insulin (±1 SEM) values are significantly different (respectively, p < 0.05 or less and
p < 0.01) at all times.
(C) Insulin tolerance tests. Insulin, 0.4 U/kg, was administered i.p. after a 5 hr fast to 14-week-old wild-type (filled circles; n = 8) and Imp2/ (open circles; n = 8)
mice maintained on HFD. The preinjection glucose values were slightly lower in the Imp2/ (p = 0.08), whereas values after insulin injection were all significantly
lower (p < 0.02 or lower).
(D) Immunoblots of insulin receptor b subunit, Akt, Akt(Ser473-P) in liver and skeletal muscle, andWAT andS6K and S6K(389-P) in skeletal muscle and liver. Three
pairs of wild-type and Imp2/ female mice 30 weeks of age on a HFD were sacrificed 7 min after i.p. injection of insulin (5 U/kg), and extracts were subjected to
immunoblot as indicated.
The bar graphs show the ratio of insulin receptor b subunit, Akt, Akt(Ser473-P), S6K, and S6K(389-P) in tissues of Imp2/ mice relative to wild-type mice. The
polypeptide immunoblots were quantified; the Akt-and S6K-phosphopeptide immunoblots were normalized for respective polypeptide content. The value for
each in the Imp2/ was divided by the corresponding value in the wild-type mice, and the ratio is shown. *p < 0.05, **p < 0.01 different from a ratio of 1.The presence of greater insulin sensitivity in the Imp2/ was
confirmed by the insulin tolerance test (Figure 3C); at a dose
of 0.4 U/kg, the Imp2/ mice showed a significantly greater
decrease in blood glucose. The abundance of the insulin recep-
tor b subunit in liver, muscle, and WAT does not differ between
wild-type and Imp2/ mice, whereas a supramaximal dose of
insulin (5 U/kg IP) induces greater relative phosphorylation of
Akt(S473) and S6K1(T389) in the tissues of the Imp2/ mice
(Figures 3D and 3E), providing further evidence of their greater
insulin responsiveness.
A variety of other hormonal measurements at different ages on
normal chow and on a HFD are shown in Table S2. Importantly,
serum IGF1 and IGFBP3 levels, measured at 4 weeks in malesC(Table S2) and at 7–8 weeks of age in females (data not shown)
are not different in wild-type and Imp2/.
Imp2–/– Mice Have Increased Energy Expenditure but
Normal Food Intake, Fat Absorption, and Physical
Activity
We next sought to define the basis for the greatly diminished fat
deposition in the Imp2/ mice, especially when maintained on
theHFD. Food intakewasmeasured onNCDandHFD, at several
ages between 6 and 20 weeks, and over intervals lasting
2–3 days up to 4weeks (Figures 4A, 4B, and S3A). No differences
were observed in the food intake of the wild-type and Imp2/
littermates. The percent of fecal weight as fat was determinedell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc. 613
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Figure 4. Food Intake, Fecal Fat, and Energy
Expenditure in Wild-Type and Imp2–/– Mice
(A) Food intake over 24 hr at two ages. (Upper)
Food intake of male wild-type (average weight,
19.1 g) and Imp2/ (average weight, 15.3 g) mice
at 4 weeks of age. (Middle) Food intake of male
wild-type and Imp2/mice at 16 weeks of age on
NCD (left; average weight, wild-type = 29.1 g;
Imp2/ = 27 g); (lower) 16-week-old male mice on
HFD (right; average weight, wild-type = 37 g;
Imp2/ = 30.9g). See also Figure S3A.
(B) Cumulative food intake of wild-type (filled
circles) and Imp2/ (open circles) male mice
measured weekly from 17 to 20 weeks of age on
NCD and HFD. Wild-type, n = 9; Imp2/, n = 7 for
both diets.
(C) Food intake, fecal weight, and percent fecal
weight as TG on a NCD (left) and HFD (right);
complete collection of feces on HFD not obtained.
Three cages each containing three wild-type
or Imp2/ male mice, 18–19 weeks of age, were
used for each diet.
(D) Body weight, composition, respiratory quo-
tient, and energy expenditure of wild-type and
Imp2/ male mice at 4 weeks of age after 4 days
on aHFD. Fourteenwild-type and 13 Imp2/male
mice were placed in acclimatization cages for
3 days before initiating 3 days’ measurements of
oxygen and carbon dioxide exchange. A HFD was
started 1 day before calorimetry and continued;
the data shown are from the last 2 days of
calorimetry. Body weight and composition were
measured at the finish of the calorimetry. Food
intake is shown in (A), upper. See also Figure S3B.
(E) Physical activity per 24 hr in X-Y direction. (Left)
Fourteen pairs of 6-week-old wild-type (average
weight = 19.1 g) and Imp2/ (average weight =
15.3 g) male mice on normal chow. (Right) Twelve
pairs of wild-type (average weight = 29.1g) and
Imp2/ / ( average weight = 27 g) mice at
16 weeks on NCD.on both diets inmice 17–20weeks of age (Figure 4C), andwas no
different in the wild-type and Imp2/mice (Figure 4C). Thus the
differential accumulation of fat mass in wild-type and Imp2/
mice on aHFD occurs in the absence ofmeasureable differences
in food intake permouse (on either diet), and in the absence of fat
malabsorption.
EE was estimated at several ages using indirect calorimetry.
Cohorts of males taken immediately after weaning (4 weeks)
were placed on a HFD, acclimatized to the metabolic cages,
and examined after 4 days on the HFD (Figure 4D): at this
time the Imp2/ males weigh slightly but significantly less
than wild-type (15 g versus 14 g, p = 0.046; Figure 4D, upper
left), a difference due entirely to a smaller lean mass (Figure 4D,
left, second from top). The RER (Figure 4D, bottom left)
and absolute EEs per animal (Figure 4D, top right) were not
different in Imp2/ as compared to wild-type. However, EE cor-
rected for TBW (Figure 4D, middle right) or lean mass (Figure 4D,
lower right) was10% higher in the Imp2/ (p = 0.01 and 0.002,
respectively). Five-week-old female wild-type and Imp2/mice614 Cell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc.placed on the HFD for 4 days were also examined by indirect
calorimetry (Figure S3B) with similar findings. Given the rapid
divergence in body size and composition after weaning (Fig-
ure 1E), the increased EE seen in the 5-week-old Imp2/ male
mice, measured at a time when their size and body composition
most closely resemble those of wild-type, provides the most reli-
able estimate of relative EE (Cannon and Nedergaard, 2011;
Kaiyala and Schwartz, 2011), as compared with later ages
(e.g., 16 weeks of age; Figure S3C) when body weight and
composition have diverged further. Finally, measurements of
physical activity taken during the calorimetry studies reveal no
differences between Imp2/ and wild-type mice (Figure 4E).
Thus, the substantially reduced deposition of fat in Imp2/
mice is attributable primarily to a modest increase in EE.
Imp2–/– Mice Exhibit Superior Defense of Core
Temperature
Given the evidence for increased EE, we examined thermogen-
esis. When maintained at room temperature (23C), the core
body temperature of wild-type and Imp2/ mice at 4, 7, and
20 weeks of age is not different, whether on normal chow or on
a HFD (Figures 5A and 5B). To parallel the calorimetry studies,
cohorts of 4-week-old male wild-type and Imp2/ mice were
placed at 4C; body temperature falls progressively in both
wild-type and Imp2/, but to a significantly greater extent in
wild-type (Figure 5B, upper). By 7 weeks of age, the ability of
Imp2/ mice fed normal chow to better defend their core
temperature is more pronounced (Figure 5B, lower); core body
temperature of Imp2/ mice remains significantly higher than
wild-type for the first 24 hr at 4C. By 48 hr, however, the body
temperatures of knockout and wild-type mice have converged
(Figure 5C).
The superior defense of core temperature in the cold-exposed
Imp2/ mice suggests a greater thermogenic response, espe-
cially in view of their smaller size/lean mass and lesser adiposity.
Thermogenesis in this circumstance is due to shivering (Block,
1994), which is evident in both cohorts and generates heat
though contractile activity (friction), and to catecholamine-
induced activation of thermogenesis in brown fat (Cannon and
Nedergaard, 2004). The latter reflects catecholamine-stimulated
mitochondrial metabolism and electron transport accompanied
by fatty acid activation of UCP1 (Fedorenko et al., 2012), which
dissipates the proton gradient as heat (Cannon and Nedergaard,
2011; Divakaruni and Brand, 2011).
Imp2–/– Brown Adipocytes Have More UCP1 Polypeptide
and Higher Uncoupled Oxygen Consumption
To estimate of the relative abundance of mitochondria in brown
fat and other tissues, we measured the activity of citrate syn-
thase (CS) and the electron transport complexes I–IV (Frazier
and Thorburn, 2012) as well as the ratio of mitochondrial DNA
to nuclear DNA. Whereas the ratio of mitochondrial DNA to
nuclear DNA is higher in most tissues of Imp2/ mice than in
wild-type mice (Figure 5D, left), no significant differences in the
activity of CS (Figure 5D, right) or of the electron transport com-
plexes (Figure S4) were detected; in addition, the level of acety-
lated PGC1a in brown fat does not differ between Imp2/ and
wild-type mice (Figure S5A). Inasmuch as CS correlates much
more closely with mitochondrial fractional area determined
by electron microscopy than does mitochondrial DNA (Larsen
et al., 2012), these data indicate that mitochondrial oxidative ca-
pacity is not different in the Imp2/. Nevertheless, the presence
of UCP1 in BAT mitochondria directs its oxidative metabolism
almost entirely to thermogenesis; we therefore examined the
abundance of the UCP1 polypeptide in brown adipose tissue
from wild-type and Imp2/ mice. In 5-week-old male wild-
type and Imp2/ mice maintained at room temperature and
fed a HFD from weaning (to parallel the conditions used for calo-
rimetry), the UCP1 polypeptide content of the Imp2/ BAT is
modestly but significantly greater than wild-type (Figure 5E),
whereas the abundance of Ucp1 mRNA does not differ (Fig-
ure S5B). In 16-week-old mice maintained at room temperature
on NCD, the UCP1 polypeptide in brown fat was also 2-fold
more abundant in the Imp2/mice than in wild-type. Moreover,
the increase in UCP1 protein abundance upon residence at 4C
for 72 hr is much more pronounced in the Imp2/ mice than in
wild-type (Figure 5F). In contrast to the differences in UCP1 poly-
peptide abundance in wild-type and Imp2/ brown fat, the levelCof Ucp1 mRNA in brown fat, whether measured by QPCR (Fig-
ure S5C; Table S3) or by deep sequencing (Table S4), although
increased markedly in both genotypes by cold exposure, is not
different in the wild-type as compared with Imp2/ mice.
Notably, cold exposure reduces the abundance of IMP2 in the
brown fat of wild-type mice by nearly 70% (Figure 5G).
We sought to determine whether the metabolic activity
of brown fat was increased in the Imp2/. Measurements of
18F-FDG uptake in vivo into the interscapular brown fat of
cold-exposed mice (Figure S6A) and of norepinephrine-stimu-
lated oxygen consumption in vitro by primary brown adipocytes
isolated from interscapular BAT (Figure S6B) each gave highly
variable results that did not reveal significantly different re-
sponses between wild-type and Imp2/. We next examined
oxygen consumption by stromal vascular cells isolated from in-
terscapular brown fat pads and differentiated into brown adipo-
cytes in vitro (Kajimura et al., 2009) (Figures 5H–5J). The extent of
differentiation was comparable for SVCs isolated from the BAT
of Imp2+/+ and Imp2/ mice, as judged by staining with oil red
O and by the abundance of a cohort of differentiation-dependent
mRNAs (Figure 5H). Despite the similar Ucp1 mRNA levels, the
abundance of the UCP1 polypeptide in the Imp2/ brown
adipocytes obtained by differentiation in vitro was 2-fold
higher than wild-type (Figure 5I), as had been observed in inter-
scapular BAT (Figure 5E). Overall oxygen consumption by the
Imp2/ brown adipocytes differentiated in vitro (Figure 5J)
was significantly greater than that of Imp2+/+ brown adipocytes;
pretreatment of the cells with isoproterenol increased the
oxygen consumption of all cells but enlarged the difference
between Imp2/ and Imp2+/+ adipocytes. In the presence of
oligomycin, the rate of uncoupled oxygen consumption was
2-fold greater in the Imp2/ adipocytes than in Imp2+/+ cells.
These results support the conclusion that the increased abun-
dance of UCP1 polypeptide in Imp2/ BAT is an integral feature
of brown fat differentiation in the absence of Imp2/.Moreover,
they demonstrate that the increased abundance of UCP1 poly-
peptide is accompanied by an increase in uncoupled oxygen
consumption.
IMP2 Binds Ucp1mRNA and Suppresses Its Translation
Given the higher UCP1 polypeptide abundance in Imp2/
versus wild-type brown fat without differences in Ucp1 mRNA
abundance, we hypothesized that IMP2, a known translational
regulator, might regulate translation of Ucp1 mRNA. Anti-IMP2
immunoprecipitates were prepared from wild-type and Imp2/
brown fat, as well from wild-type brown fat using anti-IMP2 and
nonimmune IgG (Figure 6A). The Ucp1 mRNA was specifically
associated with IMP2 using qPCR (Table S3) as well as RNA
sequencing. In RNA sequencing data we identified 83 RNAs
that exhibit greater than 1.5-fold enrichment in IMP2 immuno-
precipitates (Figure 6A; Table S4); over 40% of these candidate
IMP2 clients encode mitochondrial components, including Ucp1
(Figure 6B; Table S5).
Seeking independent confirmation, we used QPCR to esti-
mate the abundance of the top 21 of these 83 candidate IMP2
partner mRNAs, using as input total and anti-IMP2-bound
RNAs from wild-type and Imp2/ brown fat. Of the 21, 15
(71%) were confirmed to be enriched in the IMP2 IP from
wild-type BAT (Figure 6C, upper). Note that the total mRNAell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc. 615
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Figure 5. Body Temperature Regulation and
Mitochondrial Abundance in Wild-Type and
Imp2–/– Mice and Brown Adipocyte UCP1
Expression and Oxygen Consumption
(A) Rectal body temperature measured for 4
consecutive days in 20-week-old male mice
maintained on NCD (upper, WT n = 11; average
weight = 34.7 g; Imp2/ n = 9, average weight =
27.5 g) or on a HFD (lower, WT n = 9; average
weight = 48.1 g; Imp2/ n = 7, average weight =
34.9 g).
(B) Body temperature in the first hours after
exposure to 4C. Rectal temperature was
measured in five pairs of 28-day-old wild-type
(average 14.7 g) and Imp2/ (average 13.1 g)
male mice directly after weaning (upper) and in 12
pairs of 7-week-old wild-type (average 20.7 g)
and Imp2/ (average 17. 6g) male mice main-
tained on NCD, followed by their transfer from
room temperature to 4C in individual precooled
cages; rectal temperature was measured at
60 min (upper) or 30 min (lower) intervals. *p <
0.05; **p < 0.01.
(C) Body temperature during a 48 hr exposure to
4C. Rectal temperature was measured in ten
pairs of 7-week-old wild-type (average 21.2 g) and
Imp2/ (average 17.8 g) male mice maintained on
NCD, followed by their transfer from room tem-
perature to 4C as in (B), and rectal temperature
was measured at the intervals shown. *p < 0.05;
**p < 0.01.
(D) Mitochondrial DNA and citrate synthase activ-
ities in selected tissues of wild-type and Imp2/
mice. For measurement of citrate synthase (right),
five pairs of 36-day-old wild-type and Imp2/
female mice maintained on NCD were sacrificed,
and the tissues indicated were rapidly frozen;
activities were determined spectrophotometrically
(Frazier and Thorburn, 2012). Values for the res-
piratory chain enzyme activities complexes I–IV in
these same tissues are found in Figure S4. The
ratio of mitochondrial DNA to nuclear DNA (left)
was determined in three independent experi-
ments; DNA was extracted by phenol-chloroform
from littermate pairs of wild-type and Imp2/
mice placed on a HFD after weaning and
sacrificed 3 days thereafter. The abundance of
mitochondrial DNA and nuclear DNA was deter-
mined through QPCR for DNA encoding ND1 and
Pecam1, respectively. The ratio of Ct values from
three independent experiments, representing ten
pairs of wild-type and Imp2/ mice, is shown.
*p < 0.05, **p < 0.01.
(E) UCP1 polypeptide abundance in brown fat of young wild-type and Imp2/ mice.The interscapular BAT depot was removed from four pairs of 39-day-old
wild-type (average 18.3 g) and Imp2/ (average 16.1g) male mice maintained on HFD after weaning at 28 days. Each depot was divided in two; an extract
prepared from one half was immunoblotted for UCP1 and rpL26 as shown, and RNA was extracted from the other half, for measurement of Ucp1 and Gapdh
mRNA as shown in Figure S5B.
(F) UCP1 polypeptide abundance in brown and white fat of older wild-type and Imp2/ mice. The interscapular brown fat was excised from 16-week-old wild-
type and Imp2/male mice maintained on normal chow at room temperature and after 3 days at 4C; the inguinal fat pads were excised from mice maintained
at room temperature. A longer exposure is needed to detect UCP1 polypeptide in WAT than in BAT. The Ucp1 and GapdhmRNAs in BAT from 16-week-old mice
maintained at RT or after 3 days at 4C are shown in Figure S5C.
(G) Cold exposure reduces BAT IMP2 polypeptide. Five-week-old male Imp2+/+ maintained on HFD from weaning were either left at room temperature or
exposed to 4C for 72 hr. The mice were sacrificed and an extract of interscapular BAT was immunoblotted for IMP2 and RPL26. **p < 0.01.
(H) Stromal vascular cells from wild-type and Imp2/ brown fat exhibit comparable differentiation into brown adipocytes in vitro. SVCs isolated from the
interscapular brown fat of 33-day-old Imp2/ and Imp2+/+ mice were differentiated in vitro into adipocytes; a representative oil red O stain of the cells
postdifferentiation is shown. RNA was extracted and analyzed by QPCR for the transcripts indicated; the abundance of each was normalized using the
abundance of Gapdh mRNA, and the ratio of Imp2//Imp2+/+ (±SED) for each mRNA is shown.
(legend continued on next page)
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abundance for 14 of these 15 candidates, including Ucp1, is
unaltered by elimination of IMP2 (Figure 6C, lower).
To evaluate whether the absence of IMP2 altered the
translation of the candidate IMP2 client mRNAs, we prepared
postnuclear extracts of wild-type and Imp2/ brown fat. These
extracts were separated by sucrose density gradient centrifuga-
tion and the fraction of mRNAs comigrating with polysomes
measured by QPCR both for Gapdh (as a control) and of each
of the 21 candidate IMP2 clients (Figure 6D). Among the 15
QPCR-confirmed IMP2 client mRNAs, 13—including Ucp1—
show a significantly higher fractional polysomal abundance in
the Imp2/ extracts (Figure 6D). All 13 encode mitochondrial
components.
To directly test the effect of IMP2 on the translation of Ucp1
mRNA, we flanked the coding sequences of firefly luciferase
with the 50 and 30 UTR of murine Ucp1 mRNA, as well as with
several control UTRs. These controls included the 50 UTRs of
human b-globin and the human IGF2 leader 3 (L3) and leader 4
(L4). It has previously been shown that IMP2 does not bind to
the beta globin or IGF2L4 50 UTRs, but binds to the IGF2L3 50
UTR and enables translation of this mRNA by internal ribosomal
entry (Dai et al., 2011). The in vitro-transcribed RNAs were used
to program reticulocyte lysates, and their translation was moni-
tored by the level of luciferase enzyme activity in the relation to
increasing amounts of recombinant Flag-IMP2.
As expected, IMP2 does not alter the translation of luciferase
mRNAs bearing generic UTRs or the b-globin or IGF2L4 50
UTRs. As before, IMP2 causes a dose-dependent stimulation
of IGF2L3-luciferasemRNA. In contrast, addition of IMP2 causes
a progressive inhibition of Ucp1-luciferase mRNA translation
(Figure 6E).
In summary, IMP2 binds many mRNAs encoding mitochon-
drial components both in vivo and in vitro, and restrains their
steady-state rate of translation. These data support the hypoth-
esis that in the absence of IMP2, loss of translational inhibition
leads to a higher steady-state level of UCP1 polypeptide in
the brown fat, and this modest but sustained increase in UCP1
abundance contributes to the higher EE and resistance to
diet-induced obesity.
DISCUSSION
The phenotype of the Imp2/ mice includes the following: (1)
modestly smaller size, with slightly diminished linear growth
and less accrual of lean mass after weaning; (2) when fed a
HFD, there is much less fat in white adipose depots despite
similar food intake, fat absorption, and physical activity; (3)
smaller white adipose depots containing fewer adipocyte pre-
cursors and fewer mature fat cells of equal size to those in obese
wild-type littermate; (4) modestly increased EE; (5) improved
glucose tolerance, insulin sensitivity, and resistance to the
development of fatty liver; and (6) substantially longer lifespan.(I) Imp2/ brown adipocytes differentiated in vitro contain higher levels of UCP1
bar) stromal vascular cells, each set consisting of SVCs pooled from the intersca
Extracts were immunoblotted for the polypeptides indicated; the ratio of UCP1/
(J) Imp2/ brown adipocytes differentiated in vitro exhibit higher total and uncoup
(white bars) and Imp2+/+ (black bars) brown adipocytes, differentiated in vitro an
single-cell suspensions in the presence or absence of oligomycin (1 mM) using a
CImp2+/ mice did not exhibit smaller size or resistance to diet-
induced obesity, and the median survival of small cohort (ten
males + ten females) did not differ from that of the wild-type
mice in Figure 1G.
The best explanation we could identify for the differential gain
of the Imp2/ mice in fat mass, both on normal chow and the
HFD, is increased EE asmeasured by indirect calorimetry. As re-
gards the source of increased EE in the Imp2/mice, the lesser
initial fall in their core temperature consistently observed when
exposed to 4C provides an important clue. Mice maintained
at 22C–23C, far from their thermoneutral temperature
(28C–30C), are partially cold adapted, a response that involves
increased mitochondrial biogenesis and UCP1 expression in
brown fat (Cannon and Nedergaard, 2004, 2011). Imp2/
micemaintained at 23C exhibit a modestly increasedmitochon-
drial DNA content in most major tissues; however, the activities
of CS and electron transport complexes I–IV do not differ, indi-
cating that maximal oxidative capacity is unaltered. Neverthe-
less, the BAT of Imp2/ mice contains 2-fold higher content
of UCP1 polypeptide than the wild-type; thus, despite the unal-
tered electron transport capacity, the greater abundance of
UCP1 enables a greater proton leak at any level of electron trans-
port and is likely to account for the greater ability of the Imp2/
mice to defend their core temperature in response to the cate-
cholamine surge engendered by cold exposure. Interestingly,
UCP1 levels in in Imp2/ subcutaneous white fat appear dimin-
ished; this eliminates ‘‘browning’’ of white fat as the source of the
increased EE.
The mechanism underlying the increased abundance of UCP1
in Imp2/ brown fat is posttranscriptional, inasmuch as IMP2
deficiency does not alter Ucp1 mRNA abundance. Rather,
IMP2 binds Ucp1 mRNA specifically in brown fat and, as re-
flected by fractional polysomal abundance, elimination of IMP2
enhances the translational efficiency of Ucp1mRNA. IMP2 spe-
cifically inhibitsUcp1mRNA translation in vitro, by binding to un-
translated segments; thus, the improved translational efficiency
of Ucp1 mRNA in IMP2-deficient brown fat is, at least in part,
directly attributable to the elimination of IMP2. This increase in
translational efficiency is also likely to account for why, when
mice are exposed to 4C, the abundance of UCP1 polypeptide
increases more rapidly in Imp2/ brown fat, despite compara-
ble levels of Ucp1 mRNA.
Several features point to amore complex role for IMP2 inmito-
chondrial biogenesis and function beyond the control of Ucp1
mRNA translation. These include the widespread increase in
mitochondrial DNA and the enhanced translational efficiency of
many BAT mRNAs encoding mitochondrial electron transport
components in Imp2/ BAT, occurring without alteration in
the enzymatic activity of the BAT electron transport complexes.
In preliminary studies, we have observed that mitochondrial DNA
is also increased in Imp2/ (but not Imp1/) MEFs, whereas
maximal oxygen consumption is actually reduced by 50%,polypeptide than wild-type. Five sets of Imp2/ (white bar) and Imp2+/+ (black
pular BAT of four 33-day-old mice, were differentiated in vitro as in Figure 5H.
RPL26 polypeptides is shown. **p < 0.01.
led oxygen consumption than wild-type. The respiration of five sets of Imp2/
d pretreated for 6 hr with or without isoproterenol (10 mM), was measured as
Clark electrode. **p < 0.01.
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Figure 6. IMP2 Binds Ucp1 mRNA and Negatively Regulates Its Translation In Vivo and In Vitro
(A) Identification of abundant mRNAs bound to IMP2 in brown fat by RNA seq. Anti-IMP2 IPs were prepared from wild-type and Imp2/ BAT; separately, anti-
IMP2 and nonimmune IgG IPs were prepared from wild-type BAT. The RNA bound to the various IPs was purified, and equal amounts were subjected to RNA
sequencing as described in Experimental Procedures, in parallel with aliquots of poly(A)+RNA from wild-type and Imp2/ BAT. RNA abundance in the IPs was
adjusted for the abundance of that RNA in the corresponding total RNA, and RNAs enriched in the IMP2 IP were identified; considering only RNAs yieldingR100
reads in the IMP2 IPs fromwild-type BAT, 83mRNAswere found to be enriched 1.5-fold or greater in the IMP2 IPs by comparison to both the IgG IP or the IMP2 IP
from Imp2/ BAT.
(B) Subcellular localization of IMP2-bound RNAs in BAT.
(C) QPCR confirmation of relative enrichment of candidate IMP2-bound BAT RNAs as identified by RNA seq. RNAwas extracted from a set of IMP2 IPs prepared
from wild-type and Imp2/ BAT, distinct from those used in 6A, and 21 of the 83 candidate IMP2 bound BAT RNAs identified in 6A were analyzed by QPCR. The
upper bar graph shows a ratio of RNA abundance in the IP from wild-type BAT divided by it abundance in the IMP2 IP from Imp2/ BAT. The lower bar graph
shows the ratio of the abundance of the same RNAs in the total RNA extracted from wild-type and Imp2/ BAT. Gapdh RNA is included as a control previously
shown to not bind IMP2. *p < 0.05, **p < 0.01.
(D) The polysomal abundance of candidate IMP2-associated RNAs in wild-type and Imp2/ BAT. Aliquots of postnuclear extracts of BAT from four wild-type
and four Imp2/ mice, placed at 4C for 24 hr prior to sacrifice, were analyzed for Ucp1 mRNA and protein as shown in Figure S5 and then pooled. Aliquots
containing equal amounts of lysate were subjected to sucrose density gradient centrifugation; the RNA in the total extract loaded on the gradient and the RNA in
the pooled polysomal fractions were extracted, the abundance of each RNA indicated was measured by QPCR, and the percent of polysomal localization was
calculated as the ratio of polysomal abundance divided by the abundance in the total loaded, 3100. Filled bars, wild-type; open bars, Imp2/ BAT; *p < 0.05,
**p < 0.01.
(E) The effect of IMP2 on the translation of luciferase RNA flanked by heterologous untranslated segments. The coding sequence of firefly luciferase RNA was
fused to (from the left) a generic 50 and 30 UTR, the human b-globin 50 UTR and a generic 30 UTR, the human IGF2 leader 4 50 UTR and a generic 30 UTR, the human
IGF2 leader 3 50 UTR and a generic 30 UTR, and the murine Ucp1 50 UTR and 30 UTR. These RNAs were transcribed in vitro and used to program a reticulocyte
(legend continued on next page)
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suggesting that the increased mitochondrial DNA may be a
compensatory response. These findings are consistent with
the report of Janiszewska et al. (2012), who also observed that
IMP2 binds mRNAs encoding electron transport components
and that shRNAs directed at Imp2 resulted in a decrease in the
activity of complexes I and IV. Thus we speculate that IMP2, in
addition to controlling the translation of some mitochondrial
mRNAs, may also be required for the transport of these mRNAs
to the vicinity of mitochondria, where their localized translation
could facilitate cotranslational mitochondrial uptake, as occurs
in yeast (Weiss et al., 2013). Such a function would be analogous
to IMP1, which in addition to its stimulatory role in IGF2 transla-
tion (Dai et al., 2013) also binds b actin mRNA, silencing its trans-
lation and mediating its transport to the cell periphery, where it is
released consequent to IMP1 phosphorylation by cSrc.
As to the basis for the prolonged lifespan of the Imp2/mice,
we speculate that increased EE is a likely contributor: several
other mouse models with sustained increases in EE also exhibit
a lean, obesity-resistant phenotype and prolonged lifespan (e.g.,
inactivation of Rps6kb1 [Selman et al., 2009], transgenic expres-
sion of UCP1 in skeletal muscle [Gates et al., 2007], and low-
dose treatment with 2,4 dinitrophenol [Caldeira da Silva et al.,
2008]). In addition, the presence of malignancies in 4/6 healthy
but aged wild-type mice, together with the lack of detectable
malignancy in six Imp2/ littermates, raises the possibility that
the lack of the oncofetal protein and cancer biomarker IMP2
(Kessler et al., 2013) is protective against carcinogenesis.
Among the diverse array of genetic alterations known to extend
lifespan in mice (Chen et al., 2010; Selman and Withers, 2011)
are several loss-of-function mutations in the growth hormone
and IGF1 axis; although the Imp2/ mice show diminished
growth especially postweaning, serum levels of IGF1 during
and after maximal growth and levels of IGFBPs 1 and 3 are not
different from wild-type.
We also note that IMP2 is a rapamycin-sensitive substrate for
mTORC1 (Dai et al., 2011) and is also phosphorylated by
mTORC2 (Dai et al., unpublished data). Rapamycin treatment
(Harrison et al., 2009) and hypomorphic mutation of the mTOR
gene in mice each (Wu et al., 2013) prolong lifespan. Whether
this occurs by delay of senescent phenotypes or by reduced
carcinogenesis (or both) is uncertain (Wilkinson et al., 2012). It
will thus be of interest to test whether IMP2 is contributory to
the extension of lifespan engendered by inhibition or deficiency
of mTOR complex 1, and whether mTOR phosphorylation of
IMP2 is important to its lifespan-related actions.
A strong impetus to the investigation of the physiologic roles of
IMP2 is the presence in the human IMP2 gene of SNPs in intron 2
that confer increased risk for type 2 diabetes and alterations in
insulin secretion (Groenewoud et al., 2008), the b cell (Marselli
et al., 2010), and insulin resistance (e.g., Li et al., 2009). These
SNPs are noncoding and insufficient to prove that IMP2 is the
causal gene in the linked region. Our finding of substantial meta-
bolic and glycemic phenotypes in the Imp2/mice supports thelysate. Extracts of 293 cells transfected with either an empty flag vector (moc
immobilized anti-flag MC antibody, and eluted with flag peptide. The content of fl
corresponding amounts of themock flag eluate (dashed) were added to the lysate
30 min at 30C.
Ccase for IMP2 as the causal gene. The demonstration that IMP2
controls the translation of mitochondrial mRNAs and possibly
mitochondrial biogenesis focuses further efforts to understand
the role of IMP2 to a domain of energy metabolism known to
be important to both insulin secretion and insulin action in the
periphery and to be altered in human type 2 diabetes.
EXPERIMENTAL PROCEDURES
Generation of the Imp2 Targeting Construct
The construct was generated by using a genomic fragment of 12 kb containing
Imp2 exons 1 and 2 as well as flanking intron sequences of the murine gene
extracted from the RP23-163F16 BAC clone. The replacement-type targeting
construct consisted of 9.4 kb of Imp2 genomic sequences (4.4 kb in the left
homology arm [50] and 5.4 kb in the right homology arm [30]) (Figure S1).
Whole-Animal Studies
Animals used for experiments are bred by Imp2+/ ;Imp2+/ mating. Imp2/
mice and wild-type littermates were maintained on C57Bl/6J background in
a specific pathogen-free facility with 12:12 light:dark cycle and fed irradiated
chow (Prolab 5P75 Isopro 3000; 5% crude fat; PMI nutrition international) or
a HFD (D12492i; 60 kca%l fat; Research Diets Inc.). Body composition was
evaluated in live, conscious animals in triplicate by quantitative nuclear mag-
netic resonance spectroscopy (EchoMRI Analyzer; Echo Medical Systems,
Houston, TX). After mice had acclimated in individually housed metabolic
cages for 3 days, measurements of EE, food intake, and physical activity
were performed using an indirect calorimetric system (TSE Labmaster,
17826 Edison Avenue Chesterfield, MO 63005). Glucose tolerance was
measured after a 14 hr fast by i.p. injection of glucose (1 g/ kg); insulin toler-
ance was estimated after i.p. injection of insulin (0.4 U/kg) after a 5 hr fast.
Body temperature was measured a Physitemp BAT-12 rectal probe.
Brown Fat Studies
The stromal vascular compartment was isolated from interscapular brown fat,
grown to confluence, and differentiated to brown adipocytes according to
Kajimura et al. (2009) by incubation with isobuylmethylxanthine (0.5 mM),
dexamethasone (1 mM), insulin (17 nM), rosiglitazone (1 mM), and T3 (1 nM). Af-
ter 48 hr the medium was changed to contain insulin (17 nM) and rosiglitazone
(1 mM); 2 days later rosiglitazone was removed, and 2 days thereafter insulin
was reduced to 850 nM.Measurements of total respiration by cell suspensions
were taken in a Clark electrode (Strahkelvin Instruments) before and after the
addition of oligomycin (1 mM), and normalized for protein content. For IMP2 i.p.
from BAT, tissue was extracted for 10 min with tissue lyser (QIAGENe) in ice-
cold lysis buffer (140 mM KCl, 1.5 mM MgCl2, 20 mM Tris-HCl [pH 7.4], 0.5%
Nonidet P-40, 0.5 mM dithiothreitol, 1 U/mL RNase inhibitor, one complete
EDTA-free protease inhibitor cocktail tablet). The lysate was centrifuged for
10 min at 14,000 rpm; IMP2 i.p. and RNA extraction were performed as in
Dai et al. (2011). For analysis of BAT polysomes, the lysis buffer also contained
150 mg/mL cycloheximide, 1,000 U/ml RNase inhibitor (Roche diagnostics),
and 40 mM vanadyl-ribonucleoside complex (NEB). Sucrose density gradient
separation of polysomes and in vitro translation in the presence of recombi-
nant Flag-IMP2 were performed as before (Dai et al., 2013).
RNA Analyses
Total RNA was isolated using the Trizol reagent and QIAGENe RNase kit
(QIAGEN). RNA samples were examined for the integrity by Agilent bioanalyzer
prior to real time PCR (see Table S6 for primers) or short-fragment library con-
struction for Illumina sequencing (MGH next generation sequencing core).
Raw sequence FASTQ files were aligned to theMusmusculus genome version
10 (mm 10) using Tophat version 2.0.8 (http://tophat.cbcb.umd.edu) callingk, dashed) or the same vector encoding flag-IMP2 (solid) were adsorbed to
ag-IMP2 was estimated by C.B. stain, and aliquots of the flag-IMP2 (solid) and
s. Translation was estimated by the gain in luciferase activity after incubation for
ell Metabolism 21, 609–621, April 7, 2015 ª2015 Elsevier Inc. 619
Bowtie version 2.1.0 (http://bowtie-bio.sourceforge.net/manual.shtml) and
SAMtools version 0.1.18 (http://samtools.sourceforge.net/). Resulting
BAM files were quality tested using RNASeQC version 1.1.7 (http://www.
broadinstitute.org/cancer/cga/rna-seqc). Transcript assembly, abundance
estimation and differential expression were performed using Cufflinks/Cuffdiff
version 2.1.1 (http://cufflinks.cbcb.umd.edu/). Cuffdiff output files used for
subsequent analyses were pruned to include only genes with status OK and
exclude genes with fold change or test statistic approaching infinity. RNA
sequence data from liver (Figure 2E), brown fat, and IMP2 i.p.s are accessible
at GEO (to be provided).
Enzyme and Other Assays
CS was determined as in Frazier and Thorburn (2012). Immunoblots were per-
formed as in Dai et al. (2011). The ratio of nuclear and mitochondrial DNA was
quantitated by real-time PCR (Table S6).
Statistical Analysis
Comparisons between the mean ± SEM or SD of two groups were calculated
using two-way ANOVA or Student’s unpaired two-tailed t test. p values of 0.05
or less were considered statistically significant.
ACCESSION NUMBERS
RNA sequence data from liver (Fig.2E), brown fat and IMP2 IPs are accessible
at GEO (GSE66440).
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